Chlormequat Chloride Inhibits TM3 Leydig Cell Growth via Ferroptosis-Initiated Inflammation
Cells · 05.06.2024 · 13 (11) · 979
DOI: 10.3390/cells13110979 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 05.06.2024. Verfasst von Xiaoxia Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology, School of Public Health, Peking University, Beijing 100191, China. Hauptthemen laut MEDLINE: Ferroptosis, Leydig Cells, Inflammation, Cell Proliferation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Ferroptosis hallmarked by lipid peroxidation and iron homeostasis imbalance is involved in the occurrence and development of various diseases. The plant growth regulator chlormequat chloride (CCC) can contribute to the causality and exacerbation of reproductive disorders. However, the mechanism by which CCC may cause Leydig cell attenuation remains poorly understood. In this study, TM3 Leydig cells were used to investigate the inhibitory effect of CCC on cell growth and its possible mechanism. The results showed that CCC caused apoptosis, pyroptosis, ferroptosis and necroinflammation in TM3 cells. By comparing the effects of ferroptosis inhibitor Ferrostatin-1 (Fer-1) and pan-Caspase inhibitor Z-VAD-FMK (ZVF) on lipid peroxidation and Caspase-mediated regulated cell death (RCD), we found that Fer-1 was better at rescuing the growth of TM3 cells than ZVF. Although ZVF reduced mitochondrial ROS level and inhibited the activation of Caspase3 and Caspase1, it could not significantly ameliorate lipid peroxidation and the levels of IL-1β and HMGB1 like Fer-1. Therefore, ferroptosis might be a key non apoptotic RCD mode responsible for CCC-driven inflammation, leading to weakened viability and proliferation of TM3 cells. In addition, overexpression of ferritin light chain (FTL) promoted the resistance of TM3 cells to CCC-induced ferroptosis-mediated inflammation and to some extent improved the inhibition of viability and proliferation. Altogether, ferroptosis-initiated inflammation might play a key role in CCC-impaired TM3 cell growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Toxicology, School of Public Health, Peking University, Beijing 100191, China.
- Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing 100191, China.
ORCID-Profile: Wanqian Guo
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, X., Kang, C., Guo, W., Zhang, H., Xiao, Q., & Hao, W. (2024). Chlormequat Chloride Inhibits TM3 Leydig Cell Growth via Ferroptosis-Initiated Inflammation. Cells, 13(11), 979. https://doi.org/10.3390/cells13110979
Vancouver
Wang X, Kang C, Guo W, Zhang H, Xiao Q, Hao W. Chlormequat Chloride Inhibits TM3 Leydig Cell Growth via Ferroptosis-Initiated Inflammation. Cells. 2024;13(11):979. doi:10.3390/cells13110979
BibTeX
@article{Wang2024,
author = {Wang, Xiaoxia and Kang, Chenping and Guo, Wanqian and Zhang, Haoran and Xiao, Qianqian and Hao, Weidong},
title = {Chlormequat Chloride Inhibits TM3 Leydig Cell Growth via Ferroptosis-Initiated Inflammation},
journal = {Cells},
year = {2024},
volume = {13},
number = {11},
pages = {979},
doi = {10.3390/cells13110979}
}
EUVIMED